Sonic Incytes_Secondary_Colour

Sonic Incytes Medical Corp. is the developer of VelacurTM – the first handheld 3D liver health assessment solution. Cleared by the FDA, VelacurTM is a breakthrough, non-invasive imaging test that quantifies liver elasticity and attenuation with reliability and accuracy comparable to MRI. VelacurTM offers providers a fast, accurate and practical way to measure a patient’s liver health and grow their practice. In addition, it is a cost-effective tool for pharma to screen patients for NASH clinical trials and monitor therapeutic effectiveness of promising NASH drugs.

Request a private demo at or learn more at

Team Members


George Aliphtiras

Chief Executive Officer


Caitlin Schneider, PhD

Lead, Clinical Engineer


Dr. Stephen Harrison

Medical Director for Pinnacle Clinical Research and the President of Summit Clinical Research


Angela Koulyras

Director, Marketing & Communications